Universität Bern
14 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 6 name spellings.
2
Ending by 2030
Apr 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 28, 2026The maintenance fee for Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation (US 10,300,048) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
- 3 fees due Jan 2 to 25, 2027 · next Jan 2
- 3 fees due Feb 1 to 27, 2027 · next Feb 1
- 2 fees due Mar 10 to 17, 2027 · next Mar 10
- 1 fee due Apr 13, 2027The maintenance fee for Method of determining the genotype relating to hereditary nasal parakeratosis (HNPK) and nucleic acids usable in said method (US 9,157,114) comes due Apr 13, 2027. Unpaid by Oct 13, 2027, it lapses early.
- 1 fee due May 5, 2027The maintenance fee for Tricyclo-DNA Antisense Oligonucleotides, Compositions, and Methods for the Treatment of Disease (US 10,465,191) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
- 3 fees due Sep 5 to 8, 2027 · next Sep 5
- 1 fee due Oct 21, 2027The maintenance fee for Inositol Derivatives for Use in Pathological Crystallization (US 10,624,909) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
Recent changes
- 3 of the patents on this record were granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,465,191 | Tricyclo-DNA Antisense Oligonucleotides, Compositions, and Methods for the Treatment of Disease In force · High confidence | In force | High confidence | |
| US 9,763,979 | Cardioplegic preparation In force · From the USPTO record | In force | From the USPTO record | |
| US 8,885,906 | Alignment of positron emission tomographs by virtual tomographs In force · From the USPTO record | In force | From the USPTO record | |
| US 9,522,184 | CD89 activation in therapy In force · From the USPTO record | In force | From the USPTO record | |
| US 9,546,209 | Treatment of mucositis with immunoglobulin In force · From the USPTO record | In force | From the USPTO record | |
| US 9,277,861 | Automatic image optimization system, particularly for stereomicroscopes In force · From the USPTO record | In force | From the USPTO record | |
| US 10,342,622 | System and method for estimating the spatial position of a tool within an object In force · From the USPTO record | In force | From the USPTO record | |
| US 9,157,114 | Method of determining the genotype relating to hereditary nasal parakeratosis (HNPK) and nucleic acids usable in said method In force · From the USPTO record | In force | From the USPTO record | |
| US 9,731,306 | Electrospray device In force · From the USPTO record | In force | From the USPTO record | |
| US 10,286,047 | Treatment and Prevention of Remote Ischemia-Reperfusion Injury In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 55: 14 patents in force now held by others · 23 lapsed for an unpaid fee · 13 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
23 pending · 15 abandoned · 38 no status recorded